GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eli Lilly and Co (BUE:LLY) » Definitions » Cyclically Adjusted Book per Share

Eli Lilly and Co (BUE:LLY) Cyclically Adjusted Book per Share : ARS240.70 (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Eli Lilly and Co Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Eli Lilly and Co's adjusted book value per share for the three months ended in Mar. 2024 was ARS45,430.275. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ARS240.70 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Eli Lilly and Co's average Cyclically Adjusted Book Growth Rate was -2.70% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 0.10% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -1.10% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 0.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Eli Lilly and Co was 8.80% per year. The lowest was -2.00% per year. And the median was 4.40% per year.

As of today (2024-06-12), Eli Lilly and Co's current stock price is ARS17837.50. Eli Lilly and Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was ARS240.70. Eli Lilly and Co's Cyclically Adjusted PB Ratio of today is 74.11.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Eli Lilly and Co was 69.67. The lowest was 4.09. And the median was 8.33.


Eli Lilly and Co Cyclically Adjusted Book per Share Historical Data

The historical data trend for Eli Lilly and Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eli Lilly and Co Cyclically Adjusted Book per Share Chart

Eli Lilly and Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.87 223.64 303.65 532.28 1,509.99

Eli Lilly and Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 638.27 814.70 1,315.72 1,509.99 240.70

Competitive Comparison of Eli Lilly and Co's Cyclically Adjusted Book per Share

For the Drug Manufacturers - General subindustry, Eli Lilly and Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eli Lilly and Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eli Lilly and Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Eli Lilly and Co's Cyclically Adjusted PB Ratio falls into.



Eli Lilly and Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Eli Lilly and Co's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=45430.275/131.7762*131.7762
=45,430.275

Current CPI (Mar. 2024) = 131.7762.

Eli Lilly and Co Quarterly Data

Book Value per Share CPI Adj_Book
201406 523.106 100.560 685.494
201409 534.414 100.428 701.231
201412 473.448 99.070 629.750
201503 474.303 99.621 627.396
201506 480.999 100.684 629.537
201509 516.629 100.392 678.139
201512 682.536 99.792 901.291
201603 794.337 100.470 1,041.846
201606 741.502 101.688 960.902
201609 842.577 101.861 1,090.030
201612 806.838 101.863 1,043.778
201703 784.188 102.862 1,004.619
201706 844.674 103.349 1,077.009
201709 947.893 104.136 1,199.491
201712 804.914 104.011 1,019.781
201803 1,071.491 105.290 1,341.036
201806 1,073.333 106.317 1,330.361
201809 1,803.323 106.507 2,231.175
201812 1,402.379 105.998 1,743.432
201903 399.475 107.251 490.826
201906 514.433 108.070 627.282
201909 788.168 108.329 958.759
201912 650.942 108.420 791.169
202003 798.802 108.902 966.590
202006 1,171.811 108.767 1,419.699
202009 1,498.597 109.815 1,798.293
202012 1,919.788 109.897 2,301.999
202103 2,590.715 111.754 3,054.865
202106 2,552.763 114.631 2,934.566
202109 3,171.603 115.734 3,611.218
202112 3,803.523 117.630 4,260.953
202203 4,215.708 121.301 4,579.764
202206 4,328.429 125.017 4,562.458
202209 5,890.447 125.227 6,198.534
202212 7,516.182 125.222 7,909.596
202303 9,315.235 127.348 9,639.164
202306 11,188.647 128.729 11,453.525
202309 16,545.086 129.860 16,789.288
202312 16,383.981 129.419 16,682.343
202403 45,430.275 131.776 45,430.275

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Eli Lilly and Co  (BUE:LLY) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Eli Lilly and Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=17837.50/240.7
=74.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Eli Lilly and Co was 69.67. The lowest was 4.09. And the median was 8.33.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Eli Lilly and Co Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Eli Lilly and Co's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Eli Lilly and Co (BUE:LLY) Business Description

Industry
Address
Lilly Corporate Center, Indianapolis, IN, USA, 46285
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.